Halozyme Therapeutics Inc. buy StockNews.com
Start price
16.11.25
/
50%
€60.12
Target price
16.11.26
-
Performance (%)
-9.38%
Price
31.03.26
€55.92
Summary
This prediction is currently active. With a performance of -9.38%, the BUY prediction by StockNews_com is trending in the wrong direction. This prediction currently runs until 16.11.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 4.406% | 4.406% |
| iShares Core DAX® | 0.751% | -8.496% |
| iShares Nasdaq 100 | -1.405% | -2.771% |
| iShares Nikkei 225® | 0.417% | -9.291% |
| iShares S&P 500 | -0.590% | -2.868% |
Comments by StockNews_com for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for HALO provided by MarketBeat